Prostate cancer is the second most common cancer in American men. While the disease is prevalent across the country, the screening guidelines are not. Prostate cancer screenings have always been somewhat controversial because the tests often alert physicians to the presence of cancer, but there is no precise way to determine, definitively, whether the cancer […]
As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments. Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]
If you have been diagnosed with low-risk prostate cancer, it is likely you know about active surveillance, a passive form of treatment that started to grow in popularity in 2010. By 2015, 42.1% of low-risk prostate cancer patients opted for getting regular PSA tests, biopsies, and imaging tests instead of a more aggressive treatment plan. […]
Watch and listen to CyberKnife patient, Shawn, and board-certified radiation oncologist and St. Louis CyberKnife Medical Director, John Bedwinek, M.D., talk about how the CyberKnife system treats cancer.
Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.
Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.
David Morris, M.D., Radiation Oncologist and Medical Director at St. Louis CyberKnife, was a guest on Great Day Saint Louis. Watch Dr. Morris discuss prostate cancer (risk factors, signs and symptoms, current stats, etc.) and the benefits of treating it with CyberKnife technology.
Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer. The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]
When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration. While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them. That choice is often based on treatment outcomes and side effects, and […]
A recent patient treated at St. Louis CyberKnife wrote a thank you letter to the staff and physicians at our center to express their sincerest gratitude to everyone who assisted with their care. Please take a moment to read the thoughtful and kind words our former patient had to say about his CyberKnife experience. Admittedly, […]
